{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:29:17Z","timestamp":1789766957713,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.addbeh.2009.10.017","type":"journal-article","created":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T04:11:31Z","timestamp":1257048691000},"page":"229-234","source":"Crossref","is-referenced-by-count":48,"title":["An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects"],"prefix":"10.1016","volume":"35","author":[{"given":"Charles S.","family":"Wilcox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Oskooilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle S.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja K.","family":"Billes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara B.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Tollefson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Dunayevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2009.10.017_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/oby.2002.86","article-title":"Bupropion SR enhances weight loss: A 48-week double-blind, placebo-controlled trial","volume":"10","author":"Anderson","year":"2002","journal-title":"Obesity Research"},{"key":"10.1016\/j.addbeh.2009.10.017_bib3","series-title":"MMWR","first-page":"1157","article-title":"Cigarette smoking among adults \u2014 United States, 2006","year":"2007"},{"key":"10.1016\/j.addbeh.2009.10.017_bib4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajcn\/87.4.801","article-title":"Consequences of smoking for body weight, body fat distribution, and insulin resistance","volume":"87","author":"Chiolero","year":"2008","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.addbeh.2009.10.017_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4065\/82.2.186","article-title":"Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention","volume":"82","author":"Croghan","year":"2007","journal-title":"Mayo Clinic Proceedings"},{"issue":"4","key":"10.1016\/j.addbeh.2009.10.017_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003086.pub2","article-title":"Opioid antagonists for smoking cessation","author":"David","year":"2006","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.addbeh.2009.10.017_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1503\/cmaj.070256","article-title":"Pharmacotherapies for smoking cessation: A meta-analysis of randomized controlled trials","volume":"179","author":"Eisenberg","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.addbeh.2009.10.017_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2004.00131.x","article-title":"Smoking cessation and weight gain","volume":"5","author":"Filozof","year":"2004","journal-title":"Obesity Reviews"},{"key":"10.1016\/j.addbeh.2009.10.017_bib9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/oby.2001.71","article-title":"Bupropion for weight loss: An investigation of efficacy and tolerability in overweight and obese women","volume":"9","author":"Gadde","year":"2001","journal-title":"Obesity Research"},{"key":"10.1016\/j.addbeh.2009.10.017_bib10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2147\/VHRM.S3250","article-title":"Tobacco smoking cessation management: Integrating varenicline in current practice","volume":"4","author":"Galanti","year":"2008","journal-title":"Vascular Health and Risk Management"},{"key":"10.1016\/j.addbeh.2009.10.017_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.addbeh.2009.10.017_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/oby.2008.461","article-title":"Rational design of a combination medication for the treatment of obesity","volume":"17","author":"Greenway","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.addbeh.2009.10.017_bib13","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1210\/jc.2009-1350","article-title":"Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo","volume":"94","author":"Greenway","year":"2009","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.addbeh.2009.10.017_bib14","first-page":"361","article-title":"Techniques for the experimental measurement of human eating behaviour and food intake: A practical guide","volume":"19","author":"Hill","year":"1995","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1016\/j.addbeh.2009.10.017_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.addbeh.2009.10.017_bib16","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199710233371703","article-title":"A comparison of sustained-release bupropion and placebo for smoking cessation","volume":"337","author":"Hurt","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.addbeh.2009.10.017_bib17","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/oby.2002.142","article-title":"Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms","volume":"10","author":"Jain","year":"2002","journal-title":"Obesity Research"},{"key":"10.1016\/j.addbeh.2009.10.017_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.addbeh.2009.10.017_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.addbeh.2009.10.017_bib20","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/CIRCULATIONAHA.108.191261","article-title":"Heart disease and stroke statistics \u2014 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.addbeh.2009.10.017_bib31","unstructured":"Mayo Clinic. (2000). Smoke-free and living it. Mayo Clinic Nicotine Research Program Rochester, MN: Mayo Foundation for Medical Education and Research."},{"key":"10.1016\/j.addbeh.2009.10.017_bib21","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up","volume":"166","author":"Nides","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.addbeh.2009.10.017_bib22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archinte.166.6.667","article-title":"A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation","volume":"166","author":"O'Malley","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.addbeh.2009.10.017_bib23","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archinte.166.15.1571","article-title":"Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation","volume":"166","author":"Oncken","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1016\/j.addbeh.2009.10.017_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006219.pub2","article-title":"Interventions for preventing weight gain after smoking cessation","author":"Parsons","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.addbeh.2009.10.017_bib26","first-page":"45","article-title":"The Inventory of Depressive Symtomatology (IDS): Clinician (IDS-C) and self-report (ISD-SR) ratings of depressive symptoms","author":"Rush","year":"2000","journal-title":"Psychiatric Research"},{"key":"10.1016\/j.addbeh.2009.10.017_bib27","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/archinte.164.16.1797","article-title":"Bupropion for smoking cessation: A randomized trial","volume":"164","author":"Simon","year":"2004","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.addbeh.2009.10.017_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.addbeh.2007.05.012","article-title":"A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain","volume":"33","author":"Toll","year":"2008","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.addbeh.2009.10.017_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1365-2796.2003.01185.x","article-title":"A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation","volume":"254","author":"Tonnesen","year":"2003","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.addbeh.2009.10.017_bib30","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","article-title":"Bupropion SR for smoking cessation in smokers with cardiovascular disease: A multicentre, randomised study","volume":"24","author":"Tonstad","year":"2003","journal-title":"European Heart Journal"},{"issue":"9669","key":"10.1016\/j.addbeh.2009.10.017_bib32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock","year":"2009","journal-title":"Lancet"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460309002962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460309002962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:51:05Z","timestamp":1558608665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460309002962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0306460309002962"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2009.10.017","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}